Global Trends in Employee Experience for 2021 and 2022 – A Conversation with Emily Wilson of Qualtrics
January 7, 2022
Leave a comment
Tag
Illustrating how HR professionals responded to the novel Corona virus outbreak to guide their organizations through a global pandemic Viewing the crisis as an opportunity to accelerate progress already underway to decentralize and diversify Twitter’s workforce How will the transition back to the office reflect short term and long term changes to how and where we work Is there a way HR leaders can take this experience and use it to continue innovating without the catalyst of a crisis? Jennifer Christie Chief People Officer Twitter Jennifer Christie is Chief People Officer at Twitter. She leads the global People team and…
Continue reading
At the 2021 edition of the Biomanufacturing World Summit series held November 15-16 in San Diego, CA, Dan Szot and Chris Andrews of BIOVIA, Dassault Systèmes Company spoke about where the biopharmaceutical industry is today, how it has weathered the global pandemic, and the crucial role data has played in allowing organizations to understand where they are, what they need, and how things can move forward towards successful outcomes through informed decision-making. — Dassault Systèmes Company BIOVIA solutions create an unmatched scientific management environment that can help science-based organizations create and connect biological, chemical and material innovations to improve the…
Continue reading
How Bayer AG built its Cell & Gene Therapy unit New business model joining best of Biotech and best of Pharma How to build a sustainable pipeline? How to manage complexity and keep focus? What are the “must haves”? what are the learnings on common threats of significant transformations? New ways of working accelerated by COVID-19 pandemic Wolfram Carius EVP, Cell and Gene Therapy Bayer AG Prof. Wolfram Carius is the EVP, Cell and Gene Therapy at Bayer AG and is a member of the Executive Committee for Bayer Pharmaceuticals. He is based in Berlin, Germany. Prior to joining Bayer,…
Continue reading
Offering an overview of how our industry responded to the global pandemic Highlighting how our organization adapted our existing processes and programs to continue to work under extraordinary circumstances Discussing some of the key takeaways and lessons learned from the past year and a half Where do we go from here? How will AstraZeneca and the biopharmaceutical industry at large move forward from here? What are we doing today to pave the way to those objectives? Pam Cheng EVP, President Global Operations & IT AstraZeneca Pam Cheng joined AstraZeneca in 2015 as executive vice president of Global Operations and Information…
Continue reading
How learnings from the global pandemic combined with the introduction of new technology will enable the patient-centric manufacturing of the future Highlighting what the industry should do differently to achieve an ambitious future where all patients can receive lifesaving medicines safely, swiftly, reliably and affordably Exploring how and where products will be made, and how those products will be delivered by adopting system-driven planning and automation capabilities, leveraging the power of data and advanced analytics Describing a patient-centric pipeline the industry needs in order to deliver transformative therapies for all humanity A glimpse of how the world will evolve as…
Continue reading
How has working through a global pandemic impacted the way we do business? Taking stock of how we changed and why we changed. What are some of the net positives? What are some of the things where we do want to return to how things used to be? Reviewing where our organizations were five years ago and where we planned to be today, how much has COVID-19 changed the trajectory of our journeys? What are some of the lessons learned that we plan to take with us into the future? Is the community of biopharmaceutical manufacturers stronger for this experience?…
Continue reading
What are some of the unexpected lessons —good and bad— we have taken away from 2020 and 2021? Discussing examples of innovations created by necessity during the global pandemic that will continue on long into the future Taking this chapter in our working lives as an opportunity to re-evaluate, reconsider, and rethink some of the finance processes and strategies we had in place before COVID-19 How should we adjust our approach to communication, coordination, mentoring, and management in the emerging ‘new normal’ of work? Valdis Lenss Head of Finance, Marketing & Core Services Uber Valdis joined Uber in 2017 and…
Continue reading
What supply chain vulnerabilities were uncovered during the last 18 months? How could we have designed the supply chain differently if we had a crystal ball and knew about the pandemic earlier? How will our operating practices differ post-pandemic and will our organizations be structured the same way? — Bassem Shehata SVP, Supply Chain & Purchases Procter & Gamble Bassem leads the Global Oral Care Product Supply Organization and the global Health Care Purchases Organization; his responsibilities cover all the manufacturing facilities, planning centers, engineering, QA and purchases globally. This organization constitutes around 6,000 employees serving Procter & Gamble around the…
Continue reading
Learning to be more Human-Centric as business operations shift to adapt to current challenges How can leadership demonstrate compassion toward their teams? Facilitating better engagement and developing leaders working from anywhere Leading the way forward in a WFA world — Melanie Steinbach Chief People Officer Cameo Melanie (Mel) Steinbach is the Chief People Officer at Cameo, the leading marketplace connecting fans directly with tens of thousands of pop culture personalities in the form of customized video messages, live video calls and direct messages. Steinbach joins Cameo as the company’s first-ever Chief People Officer, and is responsible for human resources strategy…
Continue reading
Discussing the challenges and opportunities we have faced during a global pandemic, and how we have chosen to meet them What are the lessons we learn about ourselves, our teams, and our organizations when we are tested? Illustrating the role of a leader and the qualities necessary to succeed in the face of adversity Highlighting examples where the unforeseen has become the catalyst for positive change How should HR professionals best support, communicate, and reinforce leaders throughout our organizations? — Lars Minns Chief Human Resources Officer, NAFTA Mercedes Benz Lars N. Minns is the Chief Human Resources Officer of North…
Continue reading
What does investing in your people look like on a day-to-day ongoing basis? How does the workforce contribute to steady cumulative improvements as the engine of long-term culture change and improved productivity? Discussing motivational tools that solicit grassroots contributions: Competition, recognition, entertainment, and a sense of accomplishment Offering examples where training, mentorship, job shadowing, and cycling through different job functions improves retention, job satisfaction, and contributes to improved performance How far can a culture of continuous improvement and total workforce engagement permeate an organization? — Moderator: Angela Roseboro Chief Diversity Officer Riot Games As a 20-year Diversity and Inclusion, and…
Continue reading
Illustrating how HR professionals responded to the novel Corona virus outbreak to guide their organizations through a global pandemic Viewing the crisis as an opportunity to accelerate progress already underway to decentralize and diversify Twitter’s workforce How will the transition back to the office reflect short term and long term changes to how and where we work Is there a way HR leaders can take this experience and use it to continue innovating without the catalyst of a crisis? — Jennifer Christie VP, People and Chief Human Resources Officer Twitter Jennifer Christie is VP, People and Chief Human Resources Officer…
Continue reading
Accelerated, sequential testing (e.g., ASTM, ISTA) is no longer acceptable by the FDA for drug product testing Real-world testing cannot test the “worst-case” edges of your operating space Real-world testing in the post-COVID-19 world will be difficult and expensive
Continue reading
Pam Cheng EVP, President Global Operations & IT AstraZeneca Pam Cheng joined AstraZeneca in 2015 as executive vice president of Global Operations and Information Technology (IT), guiding the company’s manufacturing, supply chain, procurement, and IT across 18 countries and leading a team of over 19,000. Under her leadership, AstraZeneca Global Operations has transformed significantly driving top performance across the business while delivering value back to the enterprise. The next phase of transformation includes the convergence of operational excellence and digital innovation, building the ‘Factory of the Future’. Before AstraZeneca she spent 18 years in global manufacturing, supply chain, and commercial…
Continue reading
